Joost J. Oudejans

4.0k total citations
68 papers, 3.0k citations indexed

About

Joost J. Oudejans is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Joost J. Oudejans has authored 68 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 24 papers in Oncology and 22 papers in Molecular Biology. Recurrent topics in Joost J. Oudejans's work include Lymphoma Diagnosis and Treatment (39 papers), Cell death mechanisms and regulation (11 papers) and Viral-associated cancers and disorders (11 papers). Joost J. Oudejans is often cited by papers focused on Lymphoma Diagnosis and Treatment (39 papers), Cell death mechanisms and regulation (11 papers) and Viral-associated cancers and disorders (11 papers). Joost J. Oudejans collaborates with scholars based in Netherlands, United States and United Kingdom. Joost J. Oudejans's co-authors include Chris J.L.M. Meijer, Wim Vos, Rosita L. ten Berge, Danny F. Dukers, Gert J. Ossenkoppele, J. Alain Kummer, Peter C. de Bruin, P. J. van Diest, Chris J. Mulder and Abdulbaqi Al–Toma and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Joost J. Oudejans

68 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joost J. Oudejans Netherlands	34	1.3k	1.3k	815	717	386	68	3.0k
Xavier Sastre France	33	2.0k 1.5×	683 0.5×	618 0.8×	822 1.1×	492 1.3×	77	4.2k
Bjarni A. Agnarsson Iceland	27	714 0.5×	854 0.7×	344 0.4×	925 1.3×	556 1.4×	80	2.7k
Daniela Gasparotto Italy	27	810 0.6×	486 0.4×	177 0.2×	796 1.1×	253 0.7×	45	2.5k
Kennosuke Karube Japan	31	1.3k 0.9×	1.8k 1.4×	1.2k 1.5×	550 0.8×	242 0.6×	136	3.2k
Rudolf Schmits Germany	25	1.1k 0.8×	798 0.6×	2.7k 3.3×	1.4k 1.9×	343 0.9×	52	4.5k
Rosaria Bufalino Italy	29	2.3k 1.7×	625 0.5×	910 1.1×	713 1.0×	890 2.3×	58	3.6k
Yoshitoyo Kagami Japan	35	1.9k 1.4×	2.3k 1.8×	1.0k 1.3×	739 1.0×	136 0.4×	102	3.9k
Stephen Lade Australia	20	909 0.7×	1.1k 0.8×	543 0.7×	1.1k 1.5×	689 1.8×	46	3.2k
Mathijs Baens Belgium	29	959 0.7×	842 0.7×	1.2k 1.4×	1.5k 2.1×	998 2.6×	51	3.7k
Sylvia Hartmann Germany	31	1.6k 1.2×	1.6k 1.2×	759 0.9×	744 1.0×	485 1.3×	148	3.0k

Countries citing papers authored by Joost J. Oudejans

Since Specialization

Citations

This map shows the geographic impact of Joost J. Oudejans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost J. Oudejans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost J. Oudejans more than expected).

Fields of papers citing papers by Joost J. Oudejans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost J. Oudejans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost J. Oudejans. The network helps show where Joost J. Oudejans may publish in the future.

Co-authorship network of co-authors of Joost J. Oudejans

This figure shows the co-authorship network connecting the top 25 collaborators of Joost J. Oudejans. A scholar is included among the top collaborators of Joost J. Oudejans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joost J. Oudejans. Joost J. Oudejans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berkhof, Johannes, Michal Sieniawski, Wieke H.M. Verbeek, et al.. (2015). A New and Validated Clinical Prognostic Model (EPI) for Enteropathy-Associated T-cell Lymphoma. Clinical Cancer Research. 21(13). 3013–3019. 18 indexed citations

Kornegoor, Robert, Cathy B. Moelans, Anoek H J Verschuur‐Maes, et al.. (2012). Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Research and Treatment. 135(1). 49–58. 45 indexed citations

Kornegoor, Robert, Anoek H J Verschuur‐Maes, Horst Buerger, et al.. (2012). Immunophenotyping of male breast cancer. Histopathology. 61(6). 1145–1155. 26 indexed citations

Kluin‐Nelemans, Hanneke C., Marinus van Marwijk Kooy, Pieternella J. Lugtenburg, et al.. (2011). Intensified alemtuzumab–CHOP therapy for peripheral T-cell lymphoma. Annals of Oncology. 22(7). 1595–1600. 55 indexed citations

Kornegoor, Robert, Anoek H J Verschuur‐Maes, Horst Buerger, et al.. (2011). Molecular subtyping of male breast cancer by immunohistochemistry. Modern Pathology. 25(3). 398–404. 105 indexed citations

Vijver, Marc J. van de, Pieter Wesseling, Jelle Wesseling, et al.. (2010). Receptor conversion in distant breast cancer metastases. Breast Cancer Research. 12(5). R75–R75. 180 indexed citations

Oudejans, Joost J., Wessel N. van Wieringen, Serge Smeets, et al.. (2008). Identification of genes putatively involved in the pathogenesis of diffuse large B‐cell lymphomas by integrative genomics. Genes Chromosomes and Cancer. 48(3). 250–260. 6 indexed citations

Al–Toma, Abdulbaqi, Wieke H.M. Verbeek, Otto Visser, et al.. (2007). Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Digestive and Liver Disease. 39(7). 634–641. 62 indexed citations

Verbeek, Wieke H.M., Marije S. Goerres, B. Mary E. von Blomberg, et al.. (2007). Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clinical Immunology. 126(1). 48–56. 100 indexed citations

10.

Ylstra, Bauke, Joost J. Oudejans, Marianne Tijssen, et al.. (2007). Identification of novel genes related to primary nodal diffuse large B-cell lymphomas with poor outcome by array CGH and expression integration analysis. VU Research Portal. 1 indexed citations

11.

Muris, Jettie J.F., Bauke Ylstra, Saskia A.G.M. Cillessen, et al.. (2006). Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B‐cell lymphomas. British Journal of Haematology. 136(1). 38–47. 36 indexed citations

12.

Riemersma, Sietske A., Joost J. Oudejans, Enno Dreef, et al.. (2005). High numbers of tumour‐infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis. The Journal of Pathology. 206(3). 328–336. 48 indexed citations

13.

Muris, Jettie J.F., C J Meijer, Saskia A.G.M. Cillessen, et al.. (2003). Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas. Leukemia. 18(3). 589–596. 77 indexed citations

14.

Dukers, Danny F., Joost J. Oudejans, Wim Vos, Rosita L. ten Berge, & Chris J.L.M. Meijer. (2002). Apoptosis in B‐cell lymphomas and reactive lymphoid tissues always involves activation of caspase 3 as determined by a new in situ detection method. The Journal of Pathology. 196(3). 307–315. 35 indexed citations

15.

Berge, Rosita L. ten, Frank G.M. Snijdewint, Silvia von Mensdorff‐Pouilly, et al.. (2001). MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. Journal of Clinical Pathology. 54(12). 933–939. 33 indexed citations

16.

Müschen, Markus, Klaus Rajewsky, Andreas Bräuninger, et al.. (2000). Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma. The Journal of Experimental Medicine. 191(2). 387–394. 155 indexed citations

17.

Dukers, Danny F., Lies H. Jaspars, W Vos, et al.. (2000). Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease. The Journal of Pathology. 190(2). 143–149. 68 indexed citations

18.

Berge, Rosita L. ten, Danny F. Dukers, Joost J. Oudejans, et al.. (1999). Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma. Blood. 93(8). 2688–2696. 4 indexed citations

19.

Brink, Antoinette A. T. P., Danny F. Dukers, A J van den Brule, et al.. (1997). Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.. Journal of Clinical Pathology. 50(11). 911–918. 63 indexed citations

20.

Oudejans, Joost J., Robert J.C. Slebos, F.A.N. Zoetmulder, Wolter J. Mooi, & Sjoerd Rodenhuis. (1991). Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver. International Journal of Cancer. 49(6). 875–879. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact